IP Library Granted Patent US 7,914,997
Granted Patent B2
US 7,914,997 · App. 12/912,832 · Granted Mar 29, 2011

Polynucleotides for use as tags and tag complements, manufacture and use thereof

Assignee: Luminex Molecular Diagnostics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,914,997
App. No.
12/912,832
Granted
Mar 29, 2011
Kind
B2
Abstract

A family of minimally cross-hybridizing nucleotide sequences, methods of use, etc. A specific family of 210 24mers is described.

Claims (50)

1. An oligonucleotide tag or tag complement for use in a multiplex assay, wherein the tag or tag complement is selected from the group of oligonucleotides consisting of:

(SEQ ID NO: 119)

GATTGTAAATAGAAAGTGAAGTAA,

(SEQ ID NO: 122)

TTAGATGAATTGTGAAGTATTTAG,

(SEQ ID NO: 123)

GTAAGTTATGATTGATGTTATGAA,

(SEQ ID NO: 124)

GTATTGATGTTTAAAGTGTAATAG,

(SEQ ID NO: 126)

GTTTGTATTTAGATGAATAGAAAG,

(SEQ ID NO: 130)

TTAGTGTAGTAAGTTTAAAGTGTA,

(SEQ ID NO: 132)

GTTTAAAGTTAGTTGAGTTAGTAT,

(SEQ ID NO: 133)

ATAGTGTATGTAGATTATGAGATT,

(SEQ ID NO: 134)

TTGAATGATTAGTTGAGTATGATT, 

and

(SEQ ID NO: 140)

GTTATGAAATTGTTAGTGTAGATT,

including oligonucleotides complementary thereto.

2. The oligonucleotide of claim 1 , wherein one of the oligonucleotides in SEQ ID NOs: 119, 122-124, 126, 130, 132-134, and 140 does not cross-hybridize with a second, different oligonucleotide in SEQ ID NOs: 119, 122-124, 126, 130, 132-134, and 140 under the following hybridization conditions: 0.2 M NaCl, 0.1 M Tris, 0.08% Triton X-100, pH 8.0 at 37° C.

3. The oligonucleotide of claim 1 , wherein the oligonucleotide is attached to a solid support.

4. The oligonucleotide of claim 3 , wherein the solid support is a microparticle.

5. An improved method of analyzing a biological sample suspected of comprising a target, wherein the improvement comprises using the oligonucleotide tag or tag complement of claim 1 .

6. A nucleic acid tag or tag complement comprising an oligonucleotide selected from the group of oligonucleotides consisting of: SEQ ID NO: 119, SEQ ID NO: 122, SEQ ID NO: 123, SEQ ID NO: 124, SEQ ID NO: 126, SEQ ID NO: 130, SEQ ID NO: 132, SEQ ID NO: 133, SEQ ID NO: 134, and SEQ ID NO: 140, or a sequence complementary thereto, wherein the oligonucleotide is attached to a solid support.

7. The nucleic acid of claim 6 , wherein the solid support is a microparticle.

8. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 119 or the sequence complementary thereto.

9. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 122 or a sequence complementary thereto.

10. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 123 or a sequence complementary thereto.

11. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 124 or a sequence complementary thereto.

12. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 126 or a sequence complementary thereto.

13. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 130 or a sequence complementary thereto.

14. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 132 or a sequence complementary thereto.

15. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 133 or a sequence complementary thereto.

16. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 134 or a sequence complementary thereto.

17. The nucleic acid of claim 6 , wherein the oligonucleotide has the sequence set forth in SEQ ID NO: 140 or a sequence complementary thereto.

18. An improved method of analyzing a biological sample suspected of comprising a target, wherein the improvement comprises using the tag or tag complement of claim 6 .

19. A kit for sorting and identifying polynucleotides, the kit comprising at least one oligonucleotide tag or tag complement of claim 6 .

20. The kit of claim 19 , wherein each different oligonucleotide is linked to a defined location on the solid support, the defined location for each said oligonucleotide being different and distinguishable from the defined location for each different oligonucleotide.

21. The kit of claim 20 , wherein the solid support is a microparticle.

22. The kit of claim 21 , wherein each different oligonucleotide is linked to a different microparticle, each microparticle being distinguishable from each other microparticle.

23. A combination of oligonucleotide tags or tag complements for use in a multiplexed assay comprising at least one oligonucleotide set forth in SEQ ID NOs: 119, 122-124, 126, 130, 132-134, and 140 and an oligonucleotide selected from the group consisting of SEQ ID NOs: 1-210, wherein the combination comprises at least two different oligonucleotides set forth in SEQ ID NOs: 1-210.

24. The combination of claim 23 , wherein the oligonucleotides are linked to a solid support.

25. The combination of claim 24 , wherein each different oligonucleotide is linked to a defined location on the solid support, the defined location for each said oligonucleotide being different than and distinguishable from the defined location for each different oligonucleotide.

26. The combination of claim 24 , wherein the solid support is a microparticle.

27. The combination of claim 26 , wherein each different oligonucleotide is linked to a different microparticle, each microparticle being distinguishable from each other microparticle.

28. A combination comprising a plurality of oligonucleotide tags or tag complements for use in a multiplexed assay, wherein the plurality of tags or tag complements comprise SEQ ID NOs: 119, 122-124, 126, 130, 132-134, and 140 and sequences complementary thereto.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2010
From: PANCOSKA, PETR; JANOTA, VIT; BENIGHT, ALBERT S.; RICCELLI, PETER V.; KOBLER, DANIEL; FIELDHOUSE, DANIEL; BULLOCK, RICHARD S.
To: TM BIOSCIENCE CORPORATION
Reel/Frame 025442/0362 →
CHANGE OF NAME Recorded Dec 3, 2010
From: TM BIOSCIENCE CORPORATION
To: LUMINEX MOLECULAR DIAGNOSTICS, INC.
Reel/Frame 025442/0399 →
Continuity (6)
Continuation 12576878 · Oct 9, 2009
Continuation 11729302 · Mar 28, 2007
Continuation 10470107
Provisional Application 60263710 · Jan 25, 2001
Provisional Application 60303799 · Jul 10, 2001
Related Publication 20110039727A1 · Feb 17, 2011